Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shares of PTSC are again rated OUTPERFORM - or are they

Shares of PTSC are again rated OUTPERFORM - or are they

posted on Dec 01, 2008 08:23AM

Recently I reported that Reuters discontinued it's rating of PTSC. Unitl a few weeks before that it had been rated "Out Perform", Reuters' top rating.

Today the Vangaurd site again indicates that Reuters rates PTSC as Out Perform. But within the Reuters report itself there is no rating. Could even the analysists be confused about PTSC?



Share
New Message
Please login to post a reply